RECRUITING

The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A prospective study that investigates the impact of circadian rhythm disturbances due to daylight saving time transitions on migraine patients. The Primary aim is to investigate the impact of springtime DST (March 12 2023 at 2 AM on Sunday) on sleep metrics in patients with migraine headaches. Secondary aim is to examine the association between incidence of migraine headaches and sleep metrics with time transitions. Participants will be provided with a Withings non-wearable/contactless sleep tracker, which will be placed under the mattress for a period of 4 weeks (2 weeks before and 2 weeks after) during daylight saving time transition in March, 2023. Withings Health Mate app will be downloaded to the participant's smartphone to collect Sleep Data. Headache diaries will be provided to log the details of the migraines during the study period. Morningness - eveningness questionnaire (MEQ) will be used to categorize subjects on the chronotype spectrum.

Official Title

The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.

Quick Facts

Study Start:2023-02-06
Study Completion:2023-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05742191

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 years and older
  2. 2. Episodic migraine diagnosis based on ICHD 3 criteria
  3. 3. Subjects with smart phone who can download and use the Health Mate app available on iOS14 and higher and Android 8.0 and higher (Cannot be set up from a computer)
  4. 4. Subjects that can commit to sleep on the same bed/mattress every night during the study period
  5. 5. Subjects that can commit not to use sleep aids (either prescription or over the counter sleep aids) or sedating medications (sedating anti-depressants, benzodiazepines, anti-histamines, anti-psychotics or gabapentinoids) that assist with sleep onset during the study period.
  1. 1. Patients who do not meet ICHD-3 diagnostic criteria for migraine
  2. 2. Patients with migraine diagnosis who are suspected or confirmed to have active medication overuse headaches during the study period.
  3. 3. Patients who regularly use sleep aids (either prescription or over the counter sleep aids) or sedating medications (sedating anti-depressants, benzodiazepines, anti-histamines, anti-psychotics or gabapentinoids) to assist with sleep onset.
  4. 4. Participants who are planning to initiate new treatment for sleep disorders during the study period.
  5. 5. Subjects who participate in shift work.

Contacts and Locations

Study Contact

Sasikanth Gorantla, MD
CONTACT
3096244000
Sasikanth.Gorantla@osfhealthcare.org
Hrachya Nersesyan, MD, PhD
CONTACT
Hrachya.Nersesyan@ini.org

Study Locations (Sites)

OSF HealthCare Saint Francis Medical Center
Peoria, Illinois, 61637
United States

Collaborators and Investigators

Sponsor: OSF Healthcare System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-06
Study Completion Date2023-06-01

Study Record Updates

Study Start Date2023-02-06
Study Completion Date2023-06-01

Terms related to this study

Additional Relevant MeSH Terms

  • Episodic Migraine